Tech Company Financing Transactions

Cleave Biosciences Funding Round

5AM Ventures, Astellas Venture Capital and Clarus participated in a $42 million Series A funding round for Cleave Biosciences. This venture round was announced by the company on 10/11/2011.

Transaction Overview

Company Name
Cleave Biosciences
Announced On
10/11/2011
Transaction Type
Venture Equity
Amount
$42,000,000
Round
Series A
Investors

5AM Ventures

Astellas Venture Capital

Clarus

OrbiMed (Peter Thompson)

U.S. Venture Partners (Lawrence Lasky)

Proceeds Purpose
None of Cleave's drug candidates are ready yet for clinical trials, but the financing will give the company three to four years of operating cash to pursue that goal.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
863 Mitten Rd. 104
Burlingame, CA 94010
USA
Phone
(650) 443-3000
Website
www.cleavebio.com
Email Address
[email protected]
Overview
Cleave Biosciences is focused on targets in cellular protein homeostasis pathways controlled by the ubiquitin proteasome and the autophagy systems, which are utilized by cancer cells in their growth and survival.
Profile
Cleave Biosciences LinkedIn Company Profile
Social Media
Cleave Biosciences Company Twitter Account
Company News
Cleave Biosciences News
Facebook
Cleave Biosciences on Facebook
YouTube
Cleave Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Amy Burroughs
  Amy Burroughs LinkedIn Profile  Amy Burroughs Twitter Account  Amy Burroughs News  Amy Burroughs on Facebook
VP - Finance
Tanya Bowman
  Tanya Bowman LinkedIn Profile  Tanya Bowman Twitter Account  Tanya Bowman News  Tanya Bowman on Facebook
VP - Operations
Sujatha Venugopal-Prasad
  Sujatha Venugopal-Prasad LinkedIn Profile  Sujatha Venugopal-Prasad Twitter Account  Sujatha Venugopal-Prasad News  Sujatha Venugopal-Prasad on Facebook
VP - Regulatory Affairs
Kerry Kelly
  Kerry Kelly LinkedIn Profile  Kerry Kelly Twitter Account  Kerry Kelly News  Kerry Kelly on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/11/2011: Kiwi Crate venture capital transaction
Next: 10/11/2011: Advanced ICU Care venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.